Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Stephen Bradley Saad

Market Cap

66.31 Billion ZAc

Sector

Healthcare

Website

https://www.aspenpharma.com

Description

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide.

Read More

Overview

Value

18

Growth

12

Health

43

Management

24

Analyst Opinion

0

Total

24

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Has a history of share buybacks
  • Has strong dividend growth
  • Low preportion of income is paid as dividend
  • Dividend could be at risk

Risk Factors

  • Overvalued on cashflow basis
  • Earnings growth has slowed down recently
  • Poor earnings and cashflow growth

Market Peers

APN.JO

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

19.33%

Revenue Growth (5 Year Average)

-0.58%

Ratings Consensus

N/A

Share Buybacks

0.19%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

18

  • Margin-of-safety of 19.33% is better than the market average (17.95%)
  • Estimated intrinsic-value of 17.84 Thousand ZAc is higher than current price ( 14.73 Thousand ZAc)
  • Free-cashflow-yeild of N/A is worse than the market average (4.7%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: < 15819.7 ZAc

Current Price: 14952 ZAc

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

N/A

PE/Earnings Growth

N/A

Price/Book

0.95x

Growth

Growth Score

12

  • Revenue growth has improved this yeara
  • Free Cashflow growth has improved this year
  • 5 Year Average Revenue growth of -0.58% is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of 7.54% is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -16.23% is lower than the market average (12.35%)

Revenue Growth

-0.58%

Earnings Growth

7.54%

Cashflow Growth

-16.23%

Health

Health Score

43

  • Has a low level of debt
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

0.31x

Current Assets/Liabilities

1.48x

Free Cashflow/Total Debt

0.12x

Debt/Capital

0.64x

Dividend

Secure Dividend Score

25

  • Long term dividend payout ratio of 12.50% is considered good
  • Payout ratio (TTM) of N/A is lower than the average (40%)
  • Dividends have shown growth over the last 5 years
  • Spending a lower percentage of their income on dividends than last 5 years
  • Dividend yeild of N/A is less than the market average (1.85%)
  • Very unsafe
  • Dividend growth has been slowing recently

Dividend Yeild

N/A

Dividend Growth

N/A

Payout Ratio (Earnings)

N/A

Payout Ratio (Cashflow)

N/A

Management

Management Score

24

  • Has a history of returning value to shareholders through stock buybacks
  • Has returned higher dividends when earnings have risen
  • Return-on-capital-employed of 9.15% is lower than the market average (10%)
  • Has repurchased shares when overvalued
  • Return-on-equity of 0.09% is lower than the market average (15%)

Average Buybacks/Dilution

0.19%

Recent Buybacks/Dilution

-99.01%

5 Year Price Volitility

33.68%

Return On Assets

0.06%

Return On Capital Employed

9.15%

Return On Equity

0.09%

Return On Free Cashflow

1.90%

Return On Investments

N/A

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    Aspen Pharmacare Holdings Limited

    Currency

    ZAc

    Beta

    0.586012

    Vol Avg

    890393

    Ceo

    Mr. Stephen Bradley Saad

    Cik

    Cusip

    Exchange

    Johannesburg

    Full Time Employees

    8580

    Industry

    Drug Manufacturers—Specialty & Generic

    Sector

    Healthcare

    Ipo Date

    2000-01-04

    Address

    Aspen Place

    City

    Durban

    State

    Country

    ZA

    Zip

    Phone

    27 31 580 8600

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies